본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

신약 후보물질 발굴을 위한 비임상포뮬레이션 전략

이용수 98

영문명
Preclinical formulation strategies for discovering new drug candidates
발행기관
대한약학회
저자명
강원호(Won ho Kang) 채정우(Jung woo Chae) 윤휘열(Hw yeol Yun)
간행물 정보
『약학회지』제62권 제3호(2018년), 179~185쪽, 전체 7쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2018.06.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

To determine a rational preclinical formulation strategy for preclinical research, scientists should consider with their own work-flow and physicochemical properties acquired by each discovery stage. In general, physicochemical properties such as ionization states and kinetic solubility could be obtained in the early discovery stage. However, more detailed properties such as equilibrium solubility, pKa, pH-solubility and cLog P/D could be confirmed at the late discovery stage. For these reasons, it was hard to decide which kinds of formulation were most suitable for candidates. Therefore, the primary objective of this review was to figure out preclinical formulation strategy based on drug discovery stage, and propose case-study with real case for application. Preclinical formulation strategy of previously approved drug that has similar characteristics usually was used in early drug discovery stage. Especially if information of drug characteristics was limited, researchers were able to consider that it was alternative methods to make suspension with surfactant and cyclodextrin-drug complexation method. For late discovery stage, there are several ways to consider the characteristic of various physicochemical properties such as pH-adjustment, solubilization (using by co-solvent, surfactant) and combination of pH-adjustment and solubilization. As drug discovery work-flow are different among pharmaceutical companies, making preclinical formulation strategy from early stage of drug discovery is important for increment of success ratio of new drug development. This review could guide researchers which preclinical formulation is appropriate by suggesting rational strategy.

목차

Abstract
서론
본론
결론 및 고찰
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

강원호(Won ho Kang),채정우(Jung woo Chae),윤휘열(Hw yeol Yun). (2018).신약 후보물질 발굴을 위한 비임상포뮬레이션 전략. 약학회지, 62 (3), 179-185

MLA

강원호(Won ho Kang),채정우(Jung woo Chae),윤휘열(Hw yeol Yun). "신약 후보물질 발굴을 위한 비임상포뮬레이션 전략." 약학회지, 62.3(2018): 179-185

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제